PHP
NOTV

Parkman Healthcare Partners’s Inotiv NOTV Stock Holding History

Parkman Healthcare Partners’s Portfolio NOTV Stock Details NOTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-97,500
Closed -$2.85M – 89
2021
Q3 		$2.85M Sell
97,500
-17,500
-15% -$509K 0.72% 43
2021
Q2 		$3.07M Buy
115,000
+40,000
+53% +$1M 0.67% 47
2021
Q1 		$1.5M Buy
+75,000
New +$1.17M 0.35% 65

Other funds holding NOTV

PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

Parkman Healthcare Partners's NOTV Position: Q4 2021 in Review

Parkman Healthcare Partners sold out of Inotiv (NOTV) in Q4 2021, closing a stake of 97,500 shares — an estimated $2.85M sold.

Parkman Healthcare Partners first reported a position in NOTV in Q1 2021 and held it in 3 quarters. The position peaked at $3.07M in Q2 2021. 102 funds tracked by Wall St. Rank hold NOTV as of Q4 2021.

  • Parkman Healthcare Partners reported no remaining Inotiv position as of Q4 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 97,500 Inotiv shares in Q4 2021, an estimated $2.85M.
  • Parkman Healthcare Partners first reported a position in Inotiv in Q1 2021 and held it in 3 quarters.
  • Parkman Healthcare Partners's Inotiv position peaked at $3.07M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held Inotiv as of Q4 2021.

Based on Parkman Healthcare Partners's 13F filing for Q4 2021, filed 11 Feb 2022.